Serum measurement of osteoprotegerin - clinical relevance and potential applications

被引：34

作者：

Hofbauer, LC

Schoppet, M

机构：

[1] Univ Marburg, Dept Med, Div Gastroenterol Endocrinol & Metab, D-35033 Marburg, Germany

[2] Univ Marburg, Dept Med, Div Cardiol, D-35033 Marburg, Germany

来源：

EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2001年 / 145卷 / 06期

关键词：

D O I：

10.1530/eje.0.1450681

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：681 / 683

页数：3

共 22 条

[1] A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].

Anderson, DM ;

Maraskovsky, E ;

Billingsley, WL ;

Dougall, WC ;

Tometsko, ME ;

Roux, ER ;

Teepe, MC ;

DuBose, RF ;

Cosman, D ;

Galibert, L .

NATURE, 1997, 390 (6656) :175-179

[2]

Arrighi H, 2000, J BONE MINER RES, V15, pS538

[3]

ARRIGHI HM, 1998, BONE S1, V23, pT411

[4] The effect of a single dose of osteoprotegerin in postmenopausal women [J].

Bekker, PJ ;

Holloway, D ;

Nakanishi, A ;

Arrighi, M ;

Leese, PT ;

Dunstan, CR .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :348-360

[5] Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women [J].

Browner, WS ;

Lui, LY ;

Cummings, SR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :631-637

[6]

Fraher LJ, 2000, J BONE MINER RES, V15, pS441

[7] TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J].

Fuller, K ;

Wong, B ;

Fox, S ;

Choi, YW ;

Chambers, TJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :997-1001

[8]

Hofbauer LC, 2001, CANCER-AM CANCER SOC, V92, P460, DOI 10.1002/1097-0142(20010801)92:3<460::AID-CNCR1344>3.0.CO

[9]

2-D

[10] The role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases [J].

Hofbauer, LC ;

Heufelder, AE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2355-2363

← 1 2 3 →